BP-14979

DB16302InvestigationalSmall molecule

BP-14979 is under investigation in clinical trial NCT01785147 (Efficacy and Safety of BP1.4979 in Smoking Cessation).

Chemical structure of BP-14979
Mechanism
Curator reviewed
Formula / weight
C23H34N4O2 · 398.551 g/mol (avg)
Code names
BP-14979

Resolves to

Compound
UNIIXN7HA74WB0CAS1000036-77-0ChEMBLCHEMBL4297484
Structure
InChIKeyPLMAPPWZOQMTBI-XUTJKUGGSA-NSMILESCOCCC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)C2=CC=CC(=C2)C#N)CC1
Targets
P35462DRD3P14416DRD2

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with BP-14979, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In